- Patent Title: Short interfering ribonucleic acid (siRNA) for oral administration
-
Application No.: US13218941Application Date: 2011-08-26
-
Publication No.: US08344128B2Publication Date: 2013-01-01
- Inventor: Francois Jean-Charles Natt , Eric Billy , Juerg Hunziker , Christian Rene Schnell
- Applicant: Francois Jean-Charles Natt , Eric Billy , Juerg Hunziker , Christian Rene Schnell
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Frank Wu
- Priority: GB0608838.9 20060504
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/11
Abstract:
Short interfering ribonucleic acid (siRNA) for oral administration, said siRNA comprising two separate RNA strands that are complementary to each other over at least 15 nucleotides, wherein each strand is 49 nucleotides or less, and wherein at least one of which strands contains at least one chemical modification.
Public/Granted literature
- US20120029053A1 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration Public/Granted day:2012-02-02
Information query
